Catalogo dei prodotti della ricerca

SCRIVO, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.065
EU - Europa 1.481
AS - Asia 1.042
SA - Sud America 46
AF - Africa 29
OC - Oceania 2
Totale 7.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.013
IT - Italia 670
SG - Singapore 400
IN - India 314
CN - Cina 261
SE - Svezia 178
FI - Finlandia 156
UA - Ucraina 130
DE - Germania 104
GB - Regno Unito 53
CA - Canada 47
AR - Argentina 34
IE - Irlanda 33
BG - Bulgaria 27
ID - Indonesia 23
NL - Olanda 22
AT - Austria 20
TG - Togo 20
FR - Francia 19
RU - Federazione Russa 16
BE - Belgio 13
RO - Romania 9
CH - Svizzera 7
HK - Hong Kong 7
JP - Giappone 7
PH - Filippine 7
ES - Italia 5
IL - Israele 5
BR - Brasile 4
CO - Colombia 4
GR - Grecia 4
MX - Messico 4
ZA - Sudafrica 4
CL - Cile 3
DK - Danimarca 3
IR - Iran 3
JO - Giordania 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
SC - Seychelles 3
AU - Australia 2
PL - Polonia 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BZ - Belize 1
EG - Egitto 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 7.665
Salva come PNG Salva come JPEG
Città #
Fairfield 728
Chandler 386
Ashburn 373
Woodbridge 328
Seattle 307
Dearborn 306
Singapore 286
Wilmington 263
Cambridge 252
Rome 249
Houston 237
Princeton 166
Ann Arbor 152
Plano 130
San Paolo di Civitate 102
Lawrence 97
Santa Clara 95
Beijing 82
Boston 79
Millbury 73
San Diego 62
Fremont 51
Jacksonville 49
Andover 45
Milan 42
Helsinki 40
Federal 34
Dublin 33
Boardman 29
Norwalk 28
Sofia 27
Toronto 25
San Mateo 23
New York 21
Falls Church 20
Jakarta 20
Lomé 20
Des Moines 18
Nanjing 18
Kunming 17
Vienna 17
Ottawa 16
Hefei 15
Guangzhou 14
Brussels 13
Paris 13
London 11
Falkenstein 10
Indiana 10
Jinan 10
Mannheim 10
Monterotondo 10
Fasano 8
Bühl 7
Los Angeles 7
Shanghai 7
Torrimpietra 7
Lappeenranta 6
Moscow 6
Nanchang 6
Naples 6
Phoenix 6
Redwood City 6
Shenyang 6
Cappelle sul Tavo 5
Catanzaro 5
Hanover 5
Redmond 5
Washington 5
Bologna 4
Bremen 4
Catania 4
Dallas 4
Fort Worth 4
Frosinone 4
Hong Kong 4
Kariya 4
Lviv 4
Mabalacat 4
Palermo 4
Pune 4
San Gregorio da Sassola 4
Sassari 4
Southend 4
Amman 3
Amsterdam 3
Belgrade 3
Bristol 3
Changsha 3
Chengdu 3
Farra di Soligo 3
Fuzhou 3
Grafing 3
Hangzhou 3
Marietta 3
Pescara 3
Prato 3
Sacramento 3
Sesto San Giovanni 3
Sham Shui Po 3
Totale 5.673
Salva come PNG Salva come JPEG
Nome #
Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations and ocular inflammation features 143
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis 131
Tuberculosis risk and anti-tumour necrosis factor agents in rheumatoid arthritis: a critical appraisal of national registry data. 121
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study 111
1H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis 107
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients 105
Anti-carbonic anhydrase II antibodies in systemic sclerosis: Association with lung involvement 93
CD8+ T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis 92
Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders 91
Dietary Habits Bursting into the Complex Pathogenesis of Autoimmune Diseases: The Emerging Role of Salt from Experimental and Clinical Studies 88
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13 87
Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors 87
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. 86
Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al. 85
Human Polyomavirus JC presence in Chronic Inflammatory Rheumatic Diseases patients treated with anti-TNF α: evaluation of viral loads, TCR rearrangements and JCV genotyping. 83
Biological Drug Treatment of Rheumatoid Arthritis and Spondyloarthritis: Effects on QT Interval and QT Dispersion 81
Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases 81
[Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis]. 79
Human polyomavirus JC presence in chronic inflammatory rheumatic diseases patients treated with anti-TNF-α: Evaluation of JC viral loads in urine and plasma samples. 79
Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases 79
Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage 78
Metabolomics in rheumatic diseases: The potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy 78
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 77
Increased prevalence of Human Polyomavirus JC viruria in Chronic Inflammatory Rheumatic Diseases patients in treatment with anti-TNF α: a 18 month follow-up study. 77
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 77
Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level. 76
The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature 76
Comment on: 'Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study' by Moltóet al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia? 75
"In sickness and in health": the peculiar occurrence of polymyalgia rheumatica in married cohabiting couples-a case series and review of the literature. 75
Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis 74
Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases 74
Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies. 73
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study 73
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities 73
The immunology of rheumatoid arthritis 72
Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis 72
Use of a contact center telephone helpline in rheumatology outpatient management: a five-year experience analysis and patients' perception 71
The Multifunctional Role of the Chemokine System in Arthritogenic Processes 71
Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study 71
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile 71
Capitolo 9.8 Malattia IgG4-correlata 70
Inflammation as "common soil" of the multifactorial diseases 68
Metabolomics Approach in Allergic and Rheumatic Diseases 68
Autoimmune aspects of cytokine and anticytokine therapies 67
Italian Consensus Recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 67
Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist 67
Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus 64
CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome 63
Erratum. management of adult-onset still's disease with interleukin-1 inhibitors. evidence- and consensus-based statements by a panel of Italian experts 62
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica 62
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 61
Biological therapies in rheumatic diseases 60
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative 60
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists 60
Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis 59
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 59
Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents. 59
The role of interleukin-12 in immune-mediated rheumatic diseases 58
NMR-based metabolomics approach to study urines of chronic inflammatory rheumatic diseases patients. 57
Down-regulation of cytotoxic expression on peripheral blood mononuclear cells in patiens with primary Sjogren's syndrome 57
Multifunctional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with TNF antagonists. 57
Induction of remission in rheumatoid arthritis: criteria and opportunities 56
Analisi molecolare della regione genomica di controllo della trascrizione genica del Polyomavirus umano JC in pazienti trattati con farmaci biologici: dati preliminari di uno studio longitudinale. 55
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries 55
Monitoring Biological Therapies in Psoriatic Arthritis 54
Acne indotta da micofenolato mofetile in pazienti affetti da lupus eritematoso sistemico: uno studio retrospettivo. 54
Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis 53
Anti-cyclic citrullinated peptide antibodies in elderly onset rheumatoid arthritis 53
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies 53
Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study 52
Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases 51
Switching between TNFα antagonists in rheumatoid arthritis: Personal experience and review of the literature 51
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 51
Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. 51
Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs. 50
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period 50
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne 50
Protenuria in SLE: is it always lupus? 50
Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. 50
Autoantibody production in anti-TNF-alpha-treated patients. 47
Aminopeptidase N (CD13) expression on synovial fluid T lymphocytes from psoriatic arthritis patients 47
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors 46
Determinants of sleep impairment in psoriatic arthritis. an observational study with 396 patients from 14 countries 45
The conundrum of psoriatic arthritis. a pathogenetic and clinical pattern at the midpoint of autoinflammation and autoimmunity 44
Response to. cCorrespondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists'' by smerilli et al 44
Reumatoide, artrite 42
Analysis of polyomavirus JC noncoding control region rearrangements in autoimmune diseases during treatment with natalizumab and anti-TNF agents 41
Polyomavirus JC monitoring and regulatory region analysis in dynamic cohorts of immune-mediated diseases treated with biologics: an observational study. 41
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis. a real-life multicenter study 41
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study 40
Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. 40
Effectiveness of adalimumab for the treatment of psoriatic arthritis. an italian real-life retrospective study 40
ERAP1 and ERAP2 Haplotypes Influence Suboptimal HLA-B*27:05-Restricted Anti-Viral CD8+ T Cell Responses Cross-Reactive to Self-Epitopes 39
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort 38
Infezione tubercolare acuta in corso di terapia con adalimumab in pazienti negativi allo screening: descrizione di 3 casi clinici. 37
Randomized prospective crossover study evaluating the performance of Quantiferon TB Gold In-Tube in patients undergoing anti-TNF alpha treatment for screening and monitoring of latent tuberculosis infection 37
Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome. 36
“Studio cross-over prospettico randomizzato di confronto tra Quantiferon TB Gold e Test secondo Mantoux nei pazienti candidati al trattamento con farmaci biologici antagonisti del TNFα” . 36
“Detection of M. tuberculosis infection by Interferon-g Release Assays: a comparative study in HIV-infected patients and in immunosuppressed people candidates for anti-TNF-a therapy” 36
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 35
Totale 6.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.268 0 0 0 0 0 366 293 189 186 123 66 45
2020/2021598 65 56 26 56 7 58 18 55 71 111 54 21
2021/20221.564 9 104 147 53 198 76 29 151 117 126 229 325
2022/20231.396 310 314 58 140 153 134 9 76 101 26 58 17
2023/2024809 53 107 40 51 86 87 41 71 8 102 68 95
2024/2025610 52 71 120 105 140 122 0 0 0 0 0 0
Totale 8.034